Liquid biopsy test to guide treatment in metastatic prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study looks at using a simple blood test (liquid biopsy) to read tumor DNA and understand how it could affect treatment decisions. It is for adults with metastatic prostate cancer who are about to start, are receiving, or recently finished treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in Spain
- You are a man age 18 or older
- You can understand the study and sign consent before any screening
- You have metastatic (stage IV) prostate cancer confirmed by imaging scans and pathology testing
- You are currently receiving, about to receive, or recently completed treatment for metastatic prostate cancer
- Your general health/activity is fairly good (ECOG 0–1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genetic makeup of metastatic prostate cancer in a Brazilian patient group. It aims to find markers that might help guide future treatment decisions.
This study looks at how genetic testing of your tumor might affect the treatment plan for your metastatic breast cancer. It aims to help doctors choose the best therapy based on your tumor's profile.
This trial studies blood tests (liquid biopsies) in men with metastatic prostate cancer that no longer responds to hormone therapy or chemotherapy and who are receiving a type of radiation therapy called PSMA RLT. The goal is to see if these blood tests can provide useful information about the cancer and treatment response.
This trial tests a new way to find genetic changes in metastatic prostate cancer using a blood test (liquid biopsy) when tumor tissue is not available. It may help doctors choose better treatments for you.
This study helps doctors use more individualized (precision) treatment choices for people with certain advanced cancers. You may be offered study care based on your cancer details, aiming to improve treatment decisions.
This study uses a blood test to detect prostate cancer more accurately than traditional methods. It looks for genetic material from cancer cells to help decide if a prostate biopsy is needed.
Hear when a new Metastatic Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.